Current Ratio of Revance Therapeutics, Inc. from 30 Sep 2014 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Revance Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2014 to 30 Sep 2024.
  • Revance Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2024 was 418%, a 11% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Revance Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2024 418% -54% -11% 30 Sep 2024
Q2 2024 433% -60% -12% 30 Jun 2024
Q1 2024 470% +20% +4.4% 31 Mar 2024
Q4 2023 442% -6% -1.2% 31 Dec 2023
Q3 2023 473% +57% +14% 30 Sep 2023
Q2 2023 493% +107% +28% 30 Jun 2023
Q1 2023 450% 0% +0.03% 31 Mar 2023
Q4 2022 447% -90% -17% 31 Dec 2022
Q3 2022 416% -222% -35% 30 Sep 2022
Q2 2022 386% -325% -46% 30 Jun 2022
Q1 2022 450% -360% -44% 31 Mar 2022
Q4 2021 537% -360% -40% 31 Dec 2021
Q3 2021 638% -272% -30% 30 Sep 2021
Q2 2021 711% -223% -24% 30 Jun 2021
Q1 2021 810% +14% +1.7% 31 Mar 2021
Q4 2020 897% +218% +32% 31 Dec 2020
Q3 2020 910% +251% +38% 30 Sep 2020
Q2 2020 934% +267% +40% 30 Jun 2020
Q1 2020 796% +48% +6.4% 31 Mar 2020
Q4 2019 678% -138% -17% 31 Dec 2019
Q3 2019 659% -319% -33% 30 Sep 2019
Q2 2019 667% -355% -35% 30 Jun 2019
Q1 2019 748% -270% -27% 31 Mar 2019
Q4 2018 817% -103% -11% 31 Dec 2018
Q3 2018 978% +151% +18% 30 Sep 2018
Q2 2018 1022% +93% +10% 30 Jun 2018
Q1 2018 1018% -100% -8.9% 31 Mar 2018
Q4 2017 920% -474% -34% 31 Dec 2017
Q3 2017 827% -877% -51% 30 Sep 2017
Q2 2017 930% -844% -48% 30 Jun 2017
Q1 2017 1118% -548% -33% 31 Mar 2017
Q4 2016 1394% -316% -18% 31 Dec 2016
Q3 2016 1704% +125% +7.9% 30 Sep 2016
Q2 2016 1774% +194% +12% 30 Jun 2016
Q1 2016 1666% +219% +15% 31 Mar 2016
Q4 2015 1711% +714% +72% 31 Dec 2015
Q3 2015 1580% +1104% +232% 30 Sep 2015
Q2 2015 1580% 30 Jun 2015
Q1 2015 1447% 31 Mar 2015
Q4 2014 997% 31 Dec 2014
Q3 2014 476% 30 Sep 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.